Boston Scientific, Guidant settle litigation

Interventional technology providers Boston Scientific of Natick, MA, and Guidant of Indianapolis have signed an agreement to settle all outstanding patent infringement claims between the two firms.

The litigation, which involved coronary stents, coronary stent delivery systems, and dilatation catheters, will be immediately dismissed. In addition, the companies have agreed to cross-license patents in certain specified technology areas, according to Boston Scientific.

By staff writers
February 23, 2004

Related Reading

Boston Scientific gets Canadian approval, February 19, 2004

Boston Scientific expands Minnesota operations, February 18, 2004

Boston Scientific posts final 2003 results, February 2, 2004

Boston Scientific gets French reimbursement for Taxus, January 29, 2004

Boston Scientific shows uptick in preliminary 2003 results, January 14, 2004

Copyright © 2004

Page 1 of 180
Next Page